Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia.
Doubková M, Staňo Kozubík K, Radová L, Pešová M, Trizuljak J, Pál K, Svobodová K, Réblová K, Svozilová H, Vrzalová Z, Pospíšilová Š, Doubek M. Doubková M, et al. Among authors: pal k. Hum Genome Var. 2019 Mar 5;6:12. doi: 10.1038/s41439-019-0044-z. eCollection 2019. Hum Genome Var. 2019. PMID: 30854216 Free PMC article.
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.
Hernández-Sánchez M, Kotaskova J, Rodríguez AE, Radova L, Tamborero D, Abáigar M, Plevova K, Benito R, Tom N, Quijada-Álamo M, Bikos V, Martín AÁ, Pal K, García de Coca A, Doubek M, López-Bigas N, Hernández-Rivas JM, Pospisilova S. Hernández-Sánchez M, et al. Among authors: pal k. Leukemia. 2019 Feb;33(2):518-558. doi: 10.1038/s41375-018-0255-1. Epub 2018 Sep 12. Leukemia. 2019. PMID: 30209402 Free PMC article. No abstract available.
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
Malcikova J, Pavlova S, Kunt Vonkova B, Radova L, Plevova K, Kotaskova J, Pal K, Dvorackova B, Zenatova M, Hynst J, Ondrouskova E, Panovska A, Brychtova Y, Zavacka K, Tichy B, Tom N, Mayer J, Doubek M, Pospisilova S. Malcikova J, et al. Among authors: pal k. Blood. 2021 Dec 23;138(25):2670-2685. doi: 10.1182/blood.2020009530. Blood. 2021. PMID: 33945616 Free PMC article.
LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V, Plevova K, Hynst J, Pal K, Mareckova A, Reigl T, Jelinkova H, Vrzalova Z, Stranska K, Pavlova S, Panovska A, Janikova A, Doubek M, Kotaskova J, Pospisilova S. Navrkalova V, et al. Among authors: pal k. J Mol Diagn. 2021 Aug;23(8):959-974. doi: 10.1016/j.jmoldx.2021.05.007. Epub 2021 Jun 1. J Mol Diagn. 2021. PMID: 34082072 Free article.
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
Olbertova H, Plevova K, Pavlova S, Malcikova J, Kotaskova J, Stranska K, Spunarova M, Trbusek M, Navrkalova V, Dvorackova B, Tom N, Pal K, Jarosova M, Brychtova Y, Panovska A, Doubek M, Pospisilova S. Olbertova H, et al. Among authors: pal k. BMC Cancer. 2022 Feb 3;22(1):137. doi: 10.1186/s12885-022-09221-z. BMC Cancer. 2022. PMID: 35114947 Free PMC article.
770 results